The Serum Institute of India (SII) is racing to develop a vaccine against the Bundibugyo strain of Ebola, according to a report by South Africa-based media outlet IOL, as the postponement of the India-Africa Forum Summit IV — originally scheduled for 28–31 May in New Delhi — threw India's growing role as a rapid vaccine manufacturer for the African continent into sharp relief.

Why the Summit Was Postponed

The India-Africa Forum Summit IV was deferred over what officials described as an 'emerging public health situation' linked to Bundibugyo Ebola outbreaks in the Democratic Republic of Congo (DRC) and Uganda. Concerns about the safety and full participation of African leaders and delegations drove the decision. The postponement, according to the IOL report, inadvertently spotlighted India's capacity for rapid vaccine intervention.

SII's Ebola Vaccine Push

Working in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI), Oxford University, and African health stakeholders, SII is leveraging ChAdOx1 technology to produce a candidate vaccine for the Bundibugyo strain. According to reports, clinical-grade doses could be ready for trials within two to three months. The IOL report described this intervention as positioning India as 'a reliable big brother to Africa, prioritising affordable access for affected nations while working closely with African counterparts on trial preparedness and distribution planning.'

Echoes of India's Covid-19 Role

SII's Ebola push mirrors its widely recognised role during the Covid-19 pandemic, when it emerged as the world's largest vaccine manufacturer by volume, delivering billions of doses affordably for the Global South — including African nations — often at cost or at low margins. This history lends credibility to SII's current intervention, though the IOL report noted that core research and development for the Bundibugyo candidate vaccine involves contributions from other countries as well.

African Union's Response

The African Union (AU), acting through the Africa Centres for Disease Control and Prevention (Africa CDC), has declared a Public Health Emergency and is pushing for vaccines to be available by year's end. The AU's collaboration with India and international partners reflects the urgency of containing the outbreak before it spreads further across the continent.

India's Broader Support to Africa

India's engagement with Africa extends beyond vaccine manufacturing. The IOL report noted that India has donated 1,000 metric tons of food grain to Burkina Faso and extended aid to Malawi and Mozambique. However, the report also struck a cautionary note: 'Partnerships with India, CEPI, Oxford, and others are vital bridges, but true self-reliance demands sustained investment in local biotech, technology transfer, and unified regulatory frameworks.' The India-Africa Forum Summit IV, when rescheduled, is expected to place health security and vaccine equity at the centre of the agenda.